[go: up one dir, main page]

GB2327497B - Diagnostic assay for cancer - Google Patents

Diagnostic assay for cancer

Info

Publication number
GB2327497B
GB2327497B GB9815224A GB9815224A GB2327497B GB 2327497 B GB2327497 B GB 2327497B GB 9815224 A GB9815224 A GB 9815224A GB 9815224 A GB9815224 A GB 9815224A GB 2327497 B GB2327497 B GB 2327497B
Authority
GB
United Kingdom
Prior art keywords
cancer
diagnostic assay
diagnostic
assay
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9815224A
Other versions
GB2327497A (en
GB9815224D0 (en
Inventor
Richard Mark Ferrie
Gillian Ellison
Kay Callaghan
Jayne Catherine Fox
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of GB9815224D0 publication Critical patent/GB9815224D0/en
Publication of GB2327497A publication Critical patent/GB2327497A/en
Application granted granted Critical
Publication of GB2327497B publication Critical patent/GB2327497B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/16—Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
GB9815224A 1997-07-18 1998-07-15 Diagnostic assay for cancer Expired - Fee Related GB2327497B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9715034A GB9715034D0 (en) 1997-07-18 1997-07-18 Assay

Publications (3)

Publication Number Publication Date
GB9815224D0 GB9815224D0 (en) 1998-09-09
GB2327497A GB2327497A (en) 1999-01-27
GB2327497B true GB2327497B (en) 1999-12-08

Family

ID=10815987

Family Applications (2)

Application Number Title Priority Date Filing Date
GB9715034A Pending GB9715034D0 (en) 1997-07-18 1997-07-18 Assay
GB9815224A Expired - Fee Related GB2327497B (en) 1997-07-18 1998-07-15 Diagnostic assay for cancer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB9715034A Pending GB9715034D0 (en) 1997-07-18 1997-07-18 Assay

Country Status (2)

Country Link
GB (2) GB9715034D0 (en)
WO (1) WO1999004037A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7811757B2 (en) 1999-09-08 2010-10-12 Genzyme Corporation Methods for disease detection

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4794052B2 (en) 1999-04-09 2011-10-12 ジェンザイム・コーポレーション Method for detecting a nucleic acid that is an indicator of cancer
PT1206571E (en) * 1999-05-04 2004-12-31 Ortho Clinical Diagnostics Inc QUICK AND EFFECTIVE CAPTURE OF DNA FROM AN UNSECURED SAMPLE TO A CELL LYRATE REAGENT
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
WO2001042781A2 (en) * 1999-12-07 2001-06-14 Exact Sciences Corporation Supracolonic aerodigestive neoplasm detection
US6919174B1 (en) 1999-12-07 2005-07-19 Exact Sciences Corporation Methods for disease detection
US7262006B1 (en) 2000-05-01 2007-08-28 Ortho-Clinical Diagnostics, Inc. Rapid and efficient capture of DNA from sample without using cell lysing reagent
CA2424584A1 (en) * 2000-10-02 2002-04-11 Ortho-Clinical Diagnostics, Inc. Detection of ras mutations
US7776524B2 (en) 2002-02-15 2010-08-17 Genzyme Corporation Methods for analysis of molecular events
US20060252041A1 (en) * 2002-09-26 2006-11-09 Batt David B PCR-based diagnostic method of detecting a mutation in the b-raf gene
DE10345021A1 (en) * 2003-09-23 2005-05-04 Univ Potsdam Method for the non-invasive early detection of colon cancer and / or colon cancer precursor cells
CA2651995C (en) 2006-05-18 2017-04-25 Molecular Profiling Institute, Inc. System and method for determining individualized medical intervention for a disease state
US8768629B2 (en) 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
WO2011109440A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
CN107254538A (en) 2008-11-12 2017-10-17 卡里斯生命科学瑞士控股有限责任公司 The method and system of phenotype is determined using allochthon
US20110207143A1 (en) * 2008-12-19 2011-08-25 Abbott Laboratories Diagnostic test for mutations in codons 12-13 of human k-ras
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
WO2011130265A2 (en) * 2010-04-12 2011-10-20 Response Genetics, Inc. Kras primers and probes
EP2607495A1 (en) 2011-12-23 2013-06-26 Genomica S.A.U. Method for detection of KRAS mutations
JP6980375B2 (en) * 2015-12-11 2021-12-15 東洋紡株式会社 Nucleic acid amplification reagent and nucleic acid amplification method

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013075A2 (en) * 1990-02-16 1991-09-05 Orion-Yhtymä Oy Method and reagent for determining specific nucleotide variations
US5137806A (en) * 1989-12-11 1992-08-11 Board Of Regents, The University Of Texas System Methods and compositions for the detection of sequences in selected DNA molecules
GB2299166A (en) * 1993-12-16 1996-09-25 Maurice Stroun Method for diagnosing cancer
WO1996040995A1 (en) * 1995-06-07 1996-12-19 Trustees Of Dartmouth College Detection of gene sequences in biological fluids
WO1997019191A1 (en) * 1995-11-17 1997-05-29 Oegreid Dagfinn Method for detection of ki-ras mutations and kit to perform it

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0655090B1 (en) * 1992-04-27 2000-12-27 The Trustees Of Dartmouth College Detection of gene sequences in biological fluids

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5137806A (en) * 1989-12-11 1992-08-11 Board Of Regents, The University Of Texas System Methods and compositions for the detection of sequences in selected DNA molecules
WO1991013075A2 (en) * 1990-02-16 1991-09-05 Orion-Yhtymä Oy Method and reagent for determining specific nucleotide variations
GB2299166A (en) * 1993-12-16 1996-09-25 Maurice Stroun Method for diagnosing cancer
WO1996040995A1 (en) * 1995-06-07 1996-12-19 Trustees Of Dartmouth College Detection of gene sequences in biological fluids
WO1997019191A1 (en) * 1995-11-17 1997-05-29 Oegreid Dagfinn Method for detection of ki-ras mutations and kit to perform it

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Oncogene (1991) 6 857-862 (Stork P. et al.) *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7811757B2 (en) 1999-09-08 2010-10-12 Genzyme Corporation Methods for disease detection

Also Published As

Publication number Publication date
WO1999004037A1 (en) 1999-01-28
GB2327497A (en) 1999-01-27
GB9715034D0 (en) 1997-09-24
GB9815224D0 (en) 1998-09-09

Similar Documents

Publication Publication Date Title
AU1724000A (en) Diagnostic assay for cancer
GB9719044D0 (en) Assay
GB2327497B (en) Diagnostic assay for cancer
AUPP312998A0 (en) Diagnostic assay
IL108879A0 (en) Sensitive cancer assay
GB9808145D0 (en) Assay
GB9800534D0 (en) Diagnostic system
HUP0103532A3 (en) Cobalamin assay
GB9619168D0 (en) Assay
GB9610195D0 (en) Assay
GB9721240D0 (en) Assay
GB9809160D0 (en) Assay
GB9803447D0 (en) Cancer diagnosis
GB9803156D0 (en) Assay
GB9704876D0 (en) Diagnostic methods
GB9706395D0 (en) Methods for clinical diagnosis
GB9727277D0 (en) Assay
GB9704312D0 (en) Diagnostic assay
GB9719428D0 (en) Assay
GB9621256D0 (en) Assay
GB9707141D0 (en) Biological assay
IL124506A0 (en) New diagnostic assay
GB9420218D0 (en) Combined assay
GB9614477D0 (en) Assay
GB9727347D0 (en) Cancer

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20020715